JP2009538832A - 胃内でアセトアルデヒドを結合するための組成物および方法 - Google Patents

胃内でアセトアルデヒドを結合するための組成物および方法 Download PDF

Info

Publication number
JP2009538832A
JP2009538832A JP2009511536A JP2009511536A JP2009538832A JP 2009538832 A JP2009538832 A JP 2009538832A JP 2009511536 A JP2009511536 A JP 2009511536A JP 2009511536 A JP2009511536 A JP 2009511536A JP 2009538832 A JP2009538832 A JP 2009538832A
Authority
JP
Japan
Prior art keywords
composition
acetaldehyde
stomach
pepsinogen
value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009511536A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538832A5 (cg-RX-API-DMAC10.html
Inventor
オスモ・スオヴァニエミ
ヴィッレ・サラスプロ
マルッティ・マルヴォラ
ミッコ・サラスプロ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biohit Oy
Original Assignee
Biohit Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oy filed Critical Biohit Oy
Publication of JP2009538832A publication Critical patent/JP2009538832A/ja
Publication of JP2009538832A5 publication Critical patent/JP2009538832A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Dairy Products (AREA)
JP2009511536A 2006-05-22 2007-05-22 胃内でアセトアルデヒドを結合するための組成物および方法 Withdrawn JP2009538832A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80212006P 2006-05-22 2006-05-22
FI20060501A FI20060501A7 (fi) 2006-05-22 2006-05-22 Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa
PCT/FI2007/050287 WO2007135241A2 (en) 2006-05-22 2007-05-22 Composition and method for binding acetaldehyde in stomach

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013161521A Division JP6178657B2 (ja) 2006-05-22 2013-08-02 胃内でアセトアルデヒドを結合するための組成物および方法

Publications (2)

Publication Number Publication Date
JP2009538832A true JP2009538832A (ja) 2009-11-12
JP2009538832A5 JP2009538832A5 (cg-RX-API-DMAC10.html) 2010-07-08

Family

ID=38436750

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2009511536A Withdrawn JP2009538832A (ja) 2006-05-22 2007-05-22 胃内でアセトアルデヒドを結合するための組成物および方法
JP2009511537A Expired - Fee Related JP5394235B2 (ja) 2006-05-22 2007-05-22 アセトアルデヒドを結合するための食品用組成物
JP2013098512A Withdrawn JP2013177413A (ja) 2006-05-22 2013-05-08 アセトアルデヒドを結合するための食品用組成物
JP2013161521A Active JP6178657B2 (ja) 2006-05-22 2013-08-02 胃内でアセトアルデヒドを結合するための組成物および方法
JP2016147411A Withdrawn JP2016196500A (ja) 2006-05-22 2016-07-27 胃内でアセトアルデヒドを結合するための組成物および方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2009511537A Expired - Fee Related JP5394235B2 (ja) 2006-05-22 2007-05-22 アセトアルデヒドを結合するための食品用組成物
JP2013098512A Withdrawn JP2013177413A (ja) 2006-05-22 2013-05-08 アセトアルデヒドを結合するための食品用組成物
JP2013161521A Active JP6178657B2 (ja) 2006-05-22 2013-08-02 胃内でアセトアルデヒドを結合するための組成物および方法
JP2016147411A Withdrawn JP2016196500A (ja) 2006-05-22 2016-07-27 胃内でアセトアルデヒドを結合するための組成物および方法

Country Status (16)

Country Link
US (2) US20090253793A1 (cg-RX-API-DMAC10.html)
EP (2) EP2034982A1 (cg-RX-API-DMAC10.html)
JP (5) JP2009538832A (cg-RX-API-DMAC10.html)
KR (4) KR20090030272A (cg-RX-API-DMAC10.html)
CN (2) CN101668522B (cg-RX-API-DMAC10.html)
CY (1) CY1123875T1 (cg-RX-API-DMAC10.html)
DK (1) DK2049097T3 (cg-RX-API-DMAC10.html)
EA (2) EA021063B1 (cg-RX-API-DMAC10.html)
ES (1) ES2845635T3 (cg-RX-API-DMAC10.html)
FI (1) FI20060501A7 (cg-RX-API-DMAC10.html)
HU (1) HUE052428T2 (cg-RX-API-DMAC10.html)
LT (1) LT2049097T (cg-RX-API-DMAC10.html)
PL (1) PL2049097T3 (cg-RX-API-DMAC10.html)
PT (1) PT2049097T (cg-RX-API-DMAC10.html)
SI (1) SI2049097T1 (cg-RX-API-DMAC10.html)
WO (2) WO2007135241A2 (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009537613A (ja) * 2006-05-22 2009-10-29 ビオヒット・ユルキネン・オサケユキテュア アセトアルデヒドを結合するための食品用組成物
JP2015518038A (ja) * 2012-05-28 2015-06-25 ビオヒット・ユルキネン・オサケユキテュアＢｉｏｈｉｔ Ｏｙｊ 頭痛予防用組成物

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110171296A1 (en) * 2000-10-30 2011-07-14 Biohit Oyj Method and preparation for binding acetaldehyde in saliva, the stomach and the large intestine
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
JP5496616B2 (ja) * 2009-11-18 2014-05-21 フロイント産業株式会社 大腸ドラッグデリバリーシステム製剤
DE102011001768A1 (de) 2011-04-04 2012-10-04 Gunnar Frank Präparat oder Nahrungsergänzungsmittel
FI20115377A (fi) * 2011-04-18 2012-10-19 Biohit Oyj Ylempien hengitys- ja ruoansulatuselinten mikrobi-infektioihin liittyvissä tiloissa käytettäväksi tarkoitettuja lääketieteellisiä tuotteita
ITMI20120847A1 (it) * 2012-05-16 2013-11-17 Labomar S R L Formulazione per sostanze a bassa biodisponibilità.
JP2016514120A (ja) * 2013-03-12 2016-05-19 ビオヒット・ユルキネン・オサケユキテュアＢｉｏｈｉｔ Ｏｙｊ 胃腸管においてアルデヒドを結合するための経口投与用組成物
BR112015006048A2 (pt) * 2013-03-12 2017-07-04 Biohit Oyj composição encapsulada para ligação com aldeídos no estômago
FI20135503L (fi) * 2013-05-13 2014-11-14 Biohit Oyj Kysteiini tai sen johdannainen atrofisen gastriitin hoitamiseen
FI20145217A7 (fi) * 2014-03-06 2015-09-07 Biohit Oyj Koostumus aldehydien ja vapaiden radikaalien sitomiseksi ruoansulatuskanavassa
CN105267267A (zh) * 2014-06-05 2016-01-27 樊伟 L-半胱氨酸组合物在预防、清除（或消除）吸烟、饮酒时所产生的致癌因素乙醛的应用
FI127823B (en) * 2015-03-06 2019-03-15 Biohit Oyj Composition for preventing hangover symptoms
JP6009050B1 (ja) * 2015-08-21 2016-10-19 国立大学法人東北大学 飲酒による悪酔いまたは二日酔いの軽減または予防剤
US11717554B2 (en) * 2019-09-19 2023-08-08 Max R&D Llc Method for preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0421635A (ja) * 1990-05-16 1992-01-24 Suntory Ltd アセトアルデヒドの毒性抑制剤およびアセトアルデヒドの毒性抑制に有効な飲食物
JPH0789876A (ja) * 1993-09-20 1995-04-04 Shiseido Co Ltd 徐放性製剤
JPH10508608A (ja) * 1994-11-04 1998-08-25 ユーロ−セルティーク，エス．エイ． 溶融押出しによる経口投与可能なオピオイド製剤
JP2004512353A (ja) * 2000-10-30 2004-04-22 ライセンティア・リミテッド 唾液、胃、大腸におけるアセトアルデヒドを結合するための方法および製剤
JP2005528428A (ja) * 2002-05-31 2005-09-22 デシティン アルツンアインミッテル ゲーエムベーハー 活性物質の遅延放出を有する薬学的組成物およびこれらの調製方法
JP2006096757A (ja) * 1998-09-10 2006-04-13 Cv Therapeutics Inc 持続放出型ラノラジン製剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
PH22818A (en) * 1986-02-18 1989-01-19 Takeda Chemical Industries Ltd Composition and method for reducing acetaldehyde toxicity
SE462779B (sv) * 1988-10-10 1990-09-03 Lejus Medical Ab Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
EP0886519A1 (en) * 1996-11-01 1998-12-30 Ilex Oncology, Inc. Sustained release formulation containing dfmo
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
DZ2937A1 (fr) * 1998-11-12 2004-03-15 Smithkline Beecham Plc Compositions nouvelles de sensibilidants à l'insuline.
JP2000178194A (ja) * 1998-12-18 2000-06-27 Pola Chem Ind Inc 徐放性製剤
JP3715529B2 (ja) * 2000-12-19 2005-11-09 雅嗣 田中 アルコール代謝促進剤
DE10224655B4 (de) * 2002-06-03 2005-03-10 Deuter Sport & Leder Rucksack mit integriertem Kleinkindersitz
FI119571B (fi) * 2002-09-06 2008-12-31 Biohit Oyj Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
WO2004066924A2 (en) * 2003-01-24 2004-08-12 Andrx Labs Llc Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
US20050271754A1 (en) 2004-06-07 2005-12-08 Cochrane Patrick W Composition for prevention or treatment of an alcohol hangover
JP5654726B2 (ja) * 2004-10-08 2015-01-14 ビオヒット・ユルキネン・オサケユキテュアＢｉｏｈｉｔ Ｏｙｊ 唾液中のアルデヒド類を結合するための方法および製剤
FI122914B (fi) * 2005-04-01 2012-08-31 Biohit Oyj Elintarvikekoostumus asetaldehydin sitomiseksi suussa ja ruoansulatuskanavassa ja menetelmä koostumuksen valmistamiseksi
FI20060501A7 (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0421635A (ja) * 1990-05-16 1992-01-24 Suntory Ltd アセトアルデヒドの毒性抑制剤およびアセトアルデヒドの毒性抑制に有効な飲食物
JPH0789876A (ja) * 1993-09-20 1995-04-04 Shiseido Co Ltd 徐放性製剤
JPH10508608A (ja) * 1994-11-04 1998-08-25 ユーロ−セルティーク，エス．エイ． 溶融押出しによる経口投与可能なオピオイド製剤
JP2006096757A (ja) * 1998-09-10 2006-04-13 Cv Therapeutics Inc 持続放出型ラノラジン製剤
JP2004512353A (ja) * 2000-10-30 2004-04-22 ライセンティア・リミテッド 唾液、胃、大腸におけるアセトアルデヒドを結合するための方法および製剤
JP2005528428A (ja) * 2002-05-31 2005-09-22 デシティン アルツンアインミッテル ゲーエムベーハー 活性物質の遅延放出を有する薬学的組成物およびこれらの調製方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6012022424; Ａｌｃｏｈｏｌｉｓｍ　Ｃｌｉｎｉｃａｌ　ａｎｄ　Ｅｘｐｅｒｉｍｅｎｔａｌ　Ｒｅｓｅａｒｃｈ ２６，　５　Ｓｕｐｐｌ．, 2002, ｐ．１３９Ａ *
JPN6012049761; Ｃｕｒｒｅｎｔ　Ｔｈｅｒａｐｅｕｔｉｃ　Ｒｅｓｅａｒｃｈ ５８（１０）, 1997, ｐ．７２４-７３３ *
JPN6012049764; Ａｌｃｏｈｏｌｉｓｍ：　Ｃｌｉｎｉｃａｌ　ａｎｄ　Ｅｘｐｅｒｉｍｅｎｔａｌ　Ｒｅｓｅａｒｃｈ ２５（３）, ｐ．４２１-４２６ *
JPN6012049767; Ｓｃａｎｄｉｎａｖｉａｎ　Ｊｏｕｒｎａｌ　ｏｆ　Ｇａｓｔｒｏｅｎｔｅｒｏｌｏｇｙ ３７（６）, 2002, ｐ．６４８-６５５ *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009537613A (ja) * 2006-05-22 2009-10-29 ビオヒット・ユルキネン・オサケユキテュア アセトアルデヒドを結合するための食品用組成物
JP2015518038A (ja) * 2012-05-28 2015-06-25 ビオヒット・ユルキネン・オサケユキテュアＢｉｏｈｉｔ Ｏｙｊ 頭痛予防用組成物
US10092534B2 (en) 2012-05-28 2018-10-09 Biohit Oyj Composition for treating headaches

Also Published As

Publication number Publication date
KR20130099217A (ko) 2013-09-05
FI20060501A0 (fi) 2006-05-22
KR20090015986A (ko) 2009-02-12
JP2009537613A (ja) 2009-10-29
PL2049097T3 (pl) 2021-05-31
FI20060501L (fi) 2007-11-23
US20100239663A1 (en) 2010-09-23
WO2007135241A2 (en) 2007-11-29
JP2016196500A (ja) 2016-11-24
SI2049097T1 (sl) 2021-05-31
EA200802360A1 (ru) 2010-02-26
WO2007135242A1 (en) 2007-11-29
ES2845635T3 (es) 2021-07-27
CY1123875T1 (el) 2022-05-27
CN101489545A (zh) 2009-07-22
KR20090030272A (ko) 2009-03-24
EA200802361A1 (ru) 2009-06-30
JP2013177413A (ja) 2013-09-09
WO2007135241A3 (en) 2009-09-17
EP2049097A2 (en) 2009-04-22
EA019832B1 (ru) 2014-06-30
US8758812B2 (en) 2014-06-24
KR20130020733A (ko) 2013-02-27
CN101668522A (zh) 2010-03-10
EA021063B1 (ru) 2015-03-31
DK2049097T3 (da) 2021-01-25
JP6178657B2 (ja) 2017-08-09
LT2049097T (lt) 2021-02-10
US20090253793A1 (en) 2009-10-08
HUE052428T2 (hu) 2021-04-28
FI20060501A7 (fi) 2007-11-23
PT2049097T (pt) 2021-02-04
EP2049097B1 (en) 2020-11-04
CN101668522B (zh) 2015-06-24
EP2034982A1 (en) 2009-03-18
JP2013231080A (ja) 2013-11-14
JP5394235B2 (ja) 2014-01-22

Similar Documents

Publication Publication Date Title
JP6178657B2 (ja) 胃内でアセトアルデヒドを結合するための組成物および方法
JP4691312B2 (ja) 唾液、胃、大腸におけるアセトアルデヒドを結合するための方法および製剤
WO2008025877A1 (en) Method and sampling kit for assessing the condition of the gastric mucosa
TWI660726B (zh) 預防頭痛的組成物
US20160022620A1 (en) Encapsulated composition for binding aldehydes in the stomach
WO2014184435A1 (en) Cysteine or a derivative thereof for the treatment of atrophic gastritis
US20160022621A1 (en) Composition for oral administration for binding aldehydes in the gastrointestinal tract
HK1135900A (en) Composition for foodstuff for binding acetaldehyde
HK40065667A (en) Dosage regimen of ferric trimaltol

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100518

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100518

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120807

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120925

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121219

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130125

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130402

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20150324